Aviso Wealth Management Sells 5,193 Shares of CME Group Inc. (NASDAQ:CME)

Key Points

• Aviso Wealth Management has significantly reduced its stake in CME Group Inc. by 49.6%, now holding 5,283 shares valued at approximately $1.4 million.
• CME Group reported a quarterly earnings per share (EPS) of $2.96, exceeding analyst expectations of $2.91, along with a 10.4% year-over-year revenue increase.
• The company recently declared a quarterly dividend of $1.25 per share, representing an annualized payout of $5.00 and a yield of 1.8%.

Aviso Wealth Management lowered its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 49.6% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,283 shares of the financial services provider's stock after selling 5,193 shares during the quarter. Aviso Wealth Management's holdings in CME Group were worth $1,402,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of the company. Wayfinding Financial LLC purchased a new position in CME Group in the 1st quarter valued at approximately $25,000. Cornerstone Planning Group LLC lifted its holdings in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after acquiring an additional 55 shares during the last quarter. New Age Alpha Advisors LLC lifted its stake in CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the last quarter. Golden State Wealth Management LLC lifted its stake in CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares during the last quarter. Finally, Alpine Bank Wealth Management bought a new position in shares of CME Group during the first quarter valued at about $32,000. Institutional investors own 87.75% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Piper Sandler upped their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Barclays set a $298.00 price target on shares of CME Group and gave the company an "equal weight" rating in a research report on Thursday, July 24th. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Morgan Stanley boosted their price target on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Finally, JPMorgan Chase & Co. reduced their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research report on Thursday, April 24th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat, CME Group has a consensus rating of "Hold" and an average target price of $261.93.

Insider Transactions at CME Group

In other news, Director Daniel G. Kaye sold 500 shares of the company's stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the transaction, the director owned 3,668 shares in the company, valued at approximately $1,035,916.56. This represents a 12.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Charles P. Carey sold 3,000 shares of the company's stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $272.56, for a total transaction of $817,680.00. Following the completion of the transaction, the director owned 5,400 shares in the company, valued at approximately $1,471,824. This represents a 35.71% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,750 shares of company stock valued at $1,576,294. 0.30% of the stock is currently owned by insiders.

CME Group Stock Up 2.3%

CME traded up $6.34 during midday trading on Monday, reaching $287.10. The company's stock had a trading volume of 1,726,168 shares, compared to its average volume of 2,223,672. The firm has a market capitalization of $103.47 billion, a price-to-earnings ratio of 27.79, a PEG ratio of 4.99 and a beta of 0.44. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 1 year low of $196.62 and a 1 year high of $290.79. The stock's 50-day moving average is $276.07 and its 200-day moving average is $264.36.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.56 earnings per share. As a group, research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.7%. The ex-dividend date was Monday, June 9th. CME Group's dividend payout ratio is currently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.